Literature DB >> 19904003

Analgesic activity of 3-mono-substituted derivatives of dihydrofuran-2-one in experimental rodent models of pain.

Kinga Sałat1, Barbara Filipek, Krzysztof Wieckowski, Barbara Malawska.   

Abstract

Three derivatives of dihydrofuran-2-one (L-PP, L-PP1, and L-SAL) were administered by intraperitoneal injection and their analgesic activity was assayed in several models of pain. The activity of these derivatives were tested using a hot plate test, a writhing test, capsaicin- and glutamate-induced nociception, along with two models of local anesthesia, including a test for infiltration anesthesia in guinea pigs and the modified tail immersion test in mice. The results of these in vivo experiments show that these three derivatives of dihydrofuran-2-one possess analgesic activity in rodents. The ED(50) values of the tested compounds are lower or comparable to the ED(50) values of reference compounds (acetylsalicylic acid or morphine). For the most active derivative of dihydrofuran-2-one, L-PP1 (3-[4-(3-trifluoromethylphenyl)-piperazin-1-yl]-dihydrofuran-2-one dihydrochloride), the ED(50) value was: 1.34 mg/kg, 0.79 mg/kg, 2.01 mg/kg and 3.99 mg/kg in the hot plate, writhing, capsaicin- and glutamate-induced pain tests, respectively.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19904003     DOI: 10.1016/s1734-1140(09)70136-7

Source DB:  PubMed          Journal:  Pharmacol Rep        ISSN: 1734-1140            Impact factor:   3.024


  3 in total

1.  Antinociceptive activity of transient receptor potential channel TRPV1, TRPA1, and TRPM8 antagonists in neurogenic and neuropathic pain models in mice.

Authors:  Kinga Sałat; Barbara Filipek
Journal:  J Zhejiang Univ Sci B       Date:  2015-03       Impact factor: 3.066

2.  Evaluation of antinociceptive and antioxidant properties of 3-[4-(3-trifluoromethyl-phenyl)-piperazin-1-yl]-dihydrofuran-2-one in mice.

Authors:  Kinga Sałat; Katarzyna Gawlik; Jadwiga Witalis; Dorota Pawlica-Gosiewska; Barbara Filipek; Bogdan Solnica; Krzysztof Więckowski; Barbara Malawska
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-03-14       Impact factor: 3.000

3.  Evaluation of cebranopadol, a dually acting nociceptin/orphanin FQ and opioid receptor agonist in mouse models of acute, tonic, and chemotherapy-induced neuropathic pain.

Authors:  Kinga Sałat; Anna Furgała; Robert Sałat
Journal:  Inflammopharmacology       Date:  2017-10-25       Impact factor: 4.473

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.